Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 4 ( July-August, 2022 ) > List of Articles


Current Trends in the Management of Cervical Intraepithelial Neoplasia

Usha Saraiya

Keywords : Cervical intraepithelial neoplasia, Gynecologists role, Management of CIN current trends, Preventive Oncology

Citation Information : Saraiya U. Current Trends in the Management of Cervical Intraepithelial Neoplasia. J South Asian Feder Obs Gynae 2022; 14 (4):458-464.

DOI: 10.5005/jp-journals-10006-2098

License: CC BY-NC 4.0

Published Online: 22-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: Several new technologies have been introduced in clinical practice for treatment of cervical intraepithelial neoplasia (CIN). This article will review the current therapies and their outcomes. Screening of all women in the age group of 30–65 will result in a certain number of screen positive women, who will then need a proper management. The management will depend on the type of lesion and clinical assessment of the patient. Material and methods: The current modalities of management available are cryotherapy, large loop excision of transformation zone (LLETZ), thermoablation, carbon dioxide (CO2) laser, and cold knife conization (CKC). Each therapy has its own advantages and disadvantages. One has to choose the correct modality for each individual case. There is also the issue of availability and affordability for each patient. The treating physician will also be confident of the procedure in which he has experience. All modalities of the treatment are simple, rarely require anesthesia and hospitalization. Centers for treatment of CIN must be widely made available in smaller towns. Results: Each modality will be individually discussed and the literature on each will be reviewed. In this review, WHO guidelines are usually followed. Discussion: The management of CIN is long-term, and a life-time follow-up is recommended. There are some special groups of women who need special attention. These include adolescent girls, pregnant women, immuno-compromised persons, and women with other health conditions. Conclusion: In the case of a revised diagnosis of invasive cancer on biopsy of a case diagnosed as CIN, the treatment will have to be also revised. It is also necessary not to alarm the patient and her family, but to give them ample time to arrange for the treatment. Clinical significance: WHO's call for “elimination of cervical cancer” which was launched in 2018 gives a sense of urgency to the understanding of these therapies. When the screening will be extensive, a large number of CIN will be detected. They will all need correct treatment and follow-up. Each gynecologist must know what to suggest and where to refer such a case. This article will fulfill that need.

PDF Share
  1. Lindeque BG. Reproductive Health Library of WHO. 2009.
  2. World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013. Available at: Accessed: 20 June 2019.
  3. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. 2nd edition. Geneva: World Health Organization; 2014
  4. Prabhakaran R, Sucheta S, Thara S, et al. Effectiveness and safety of loop electrosurgical excision procedure in a low resource setting. Int. J Gynaecol Obstet 2008;103(2):105–110. DOI: 10.1016/j.ijgo.2008.06.020.
  5. World Health Organization. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. 2019. ISBN 978-92-4-155059-8.
  6. Bar-Am A, Daniel Y, Ron IG, et al. Combined colposcopy, loop conisation, and laser vaporization reduces recurrent abnormal cytology and residual disease in cervical dysplasia. Gynecol Oncol 2000;78(1):47–51. DOI: 10.1006/gyno.2000.5825.
  7. Ortoft G, Henriksen TB, Hansen ES, et al. After conisation of the cervix, the perinatal mortality as a result of preterm delivery increases in subsequent pregnancy. BJOG 2010;117(3);258–267. DOI: 10.1111/j.1471-0528.2009.02438.x.
  8. Bruisma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix a systematic review and meta-analysis. International BJOG 2011;118(9):1031–1041. DOI: 10.1111/j.1471-0528.2011.02944.x.
  9. Kim ML et al. “The safety of conisation in the management of adenocarcinoma in situ of the uterine cervix”. Journal of Gynecologic Oncology, 2011, 22(1):25–31.
  10. The Federation of Obstetric and Gynaecological Societies of India. Good clinical practice recommendations (GCPR) on screening and treatment of preinvasive lesions of cervix and HPV vaccination 2018. Available at:
  11. Strander B, Andersson-Ellstrom A, Milsom I, et al. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 2007:335:1077.
  12. Strander B, Hallgren J, Sparen P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. Brit Med J 2014:348:f7361 DOI: 10.1136/bmj.f7361.
  13. Melniknow J, McGahan C, Sawaya GF, et al. Cervical intraepithelial neoplasia outcome after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst 2009;101(10):721–728. DOI: 10.1093/jnci/djp089.
  14. Kesic V, Miniello G, Saraiya U, et al. Modern management of abnormal cervical smears in pregnant women. Colour Atlas of Cytology and Colposcopy. New Delhi: CBS Publishers 1998; pp. 189–204.
  15. Radical Trachelectomy. Recommendations from Canadian Cancer Society. Available at: Accessed on 1st July 2022.
  16. IARC/WHO. GLOBOCAN 2020: Estimated cancer incidence, mortality & prevalence worldwide in 2020.Cervical Cancer Fact Sheet. Available at: https// Accessed on 1st July 2022.
  17. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd edition 2021. Accessed on 7th July, 2022.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.